<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Population-based studies on the epidemiology of primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp> (PSC) are sparse </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: To investigate mortality and risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, and to identify risk factors for hepatobiliary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and the combined end-point liver related <z:hpo ids='HP_0011420'>death</z:hpo> or liver transplantation (OLT) in a population-based PSC cohort in Västra Götaland, Sweden </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp> cases were identified in diagnostic registries </plain></SENT>
<SENT sid="3" pm="."><plain>Case validation and follow up was provided through individual review of case files and linkage to the Swedish <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> and Cause of <z:hpo ids='HP_0011420'>Death</z:hpo> registries </plain></SENT>
<SENT sid="4" pm="."><plain>Standardized mortality ratio (SMR) and standardized incidence ratio (SIR) for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were calculated in relation to the background population </plain></SENT>
<SENT sid="5" pm="."><plain>Cox's proportional hazards analysis was used to calculate crude and adjusted relative risks (RRs) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: A total of 199 PSC patients were identified between 1992 and 2005 </plain></SENT>
<SENT sid="7" pm="."><plain>SMR in the PSC cohort was 4.20 (95% confidence interval (CI), 3.01-5.69) </plain></SENT>
<SENT sid="8" pm="."><plain>SIR for hepatobiliary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, <z:mpath ids='MPATH_354'>cholangiocarcinoma</z:mpath> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> were 177 (110-271), 868 (505-1390) and 2.87 (0.33-10.4) respectively </plain></SENT>
<SENT sid="9" pm="."><plain>Age (RR=1.25 (1.01-1.53) per decade), female gender (RR=2.01 (1.09-3.72)), <z:mp ids='MP_0003254'>cholangitis</z:mp> (RR=2.56 (1.20-5.64)) and <z:chebi fb="0" ids="16990">bilirubin</z:chebi> (RR=3.95 (1.96-10.75) highest vs lowest quartile) were associated with the risk of liver related <z:hpo ids='HP_0011420'>death</z:hpo> or OLT </plain></SENT>
<SENT sid="10" pm="."><plain>Age was associated with the risk of hepatobiliary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (RR 1.40 (1.01-1.95) per decade) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Primary sclerosing <z:mp ids='MP_0003254'>cholangitis</z:mp> was associated with a four-fold increase in mortality in this population-based study </plain></SENT>
<SENT sid="12" pm="."><plain>In accordance with previous studies, the risk of hepatobiliary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was dramatically increased </plain></SENT>
<SENT sid="13" pm="."><plain>However, the increased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> reported in previous studies could not be confirmed </plain></SENT>
</text></document>